drugset / Trial / NCT04604678
Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19
RandomizedParallel-groupOpen-labelTreatment
Summary
Study into the effects of daily use of metformin and low-dose naltrexone (LDN) for 4 weeks to reduce symptoms, disease severity, and recovery time from COVID-19.
Timeline
- Start
- 2021-02
- Primary completion
- 2021-08
- Completion
- 2021-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 1500 mg | — |
| Subject | Naltrexone | Small molecule | 4.5 mg | — |